Related references
Note: Only part of the references are listed.Estimating the impact of wide scale uptake of screening and medications for opioid use disorder in US prisons and jails
Alexandria Macmadu et al.
DRUG AND ALCOHOL DEPENDENCE (2020)
COVID-19 Cases and Deaths in Federal and State Prisons
Brendan Saloner et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Barbara R. Haight et al.
LANCET (2019)
Long-term safety of a weekly and monthly subcutaneous buprenorphine depot (CAM2038) in the treatment of adult out-patients with opioid use disorder
Michael Frost et al.
ADDICTION (2019)
What place for prolonged-release buprenorphine depot-formulation Buvidal® in the treatment arsenal of opioid dependence? Insights from the French experience on buprenorphine
Florence Vorspan et al.
EXPERT OPINION ON DRUG DELIVERY (2019)
Effectiveness of medication assisted treatment for opioid use in prison and jail settings: A meta-analysis and systematic review
Kelly E. Moore et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2019)
Prevalence of Drug Injection, Sexual Activity, Tattooing, and Piercing Among Prison Inmates
Babak Moazen et al.
EPIDEMIOLOGIC REVIEWS (2018)
Weekly and Monthly Subcutaneous Buprenorphine Depot Formulations vs Daily Sublingual Buprenorphine With Naloxone for Treatment of Opioid Use Disorder A Randomized Clinical Trial
Michelle R. Lofwall et al.
JAMA INTERNAL MEDICINE (2018)
Substance use disorders in prisoners: an updated systematic review and meta-regression analysis in recently incarcerated men and women
Seena Fazel et al.
ADDICTION (2017)
Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in England
John Marsden et al.
ADDICTION (2017)
Prescription opioid abuse in prison settings: A systematic review of prevalence, practice and treatment responses
Zanib Bi-Moharnmed et al.
DRUG AND ALCOHOL DEPENDENCE (2017)
Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees
Kate Dolan et al.
LANCET (2016)
The extramedical use and diversion of opioid substitution medications and other medications in prison settings in Australia following the introduction of buprenorphine-naloxone film
Nancy White et al.
DRUG AND ALCOHOL REVIEW (2016)
A cost-effectiveness analysis of opioid substitution therapy upon prison release in reducing mortality among people with a history of opioid dependence
Natasa Gisev et al.
ADDICTION (2015)
Comparative prices of diverted buprenorphine/naloxone and buprenorphine in a UK prison setting: A cross-sectional survey of drug using prisoners
Nat M. J. Wright et al.
DRUG AND ALCOHOL DEPENDENCE (2014)
A randomized controlled trial of prison-initiated buprenorphine: Prison outcomes and community treatment entry
Michael S. Gordon et al.
DRUG AND ALCOHOL DEPENDENCE (2014)
Opioid substitution therapy as a strategy to reduce deaths in prison: retrospective cohort study
Sarah Larney et al.
BMJ OPEN (2014)
Validation and implementation of the Australian Treatment Outcomes Profile in specialist drug and alcohol settings
Anni Ryan et al.
DRUG AND ALCOHOL REVIEW (2014)
The Cost of Providing Methadone Maintenance Treatment in Ontario, Canada
Gregory S. Zaric et al.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2012)
Meta-analysis of drug-related deaths soon after release from prison
Elizabeth L. C. Merrall et al.
ADDICTION (2010)
Value for money in drug treatment: economic evaluation of prison methadone
Emma Warren et al.
DRUG AND ALCOHOL DEPENDENCE (2006)
Share Paper
